Infliximab Azathioprine Or Combination Therapy For Crohn S Disease Nejm
![infliximab azathioprine or Combination therapy for Crohn s di infliximab azathioprine or Combination therapy for Crohn s di](https://www.nejm.org/cms/asset/b32eed78-ac1a-4c8a-b72c-8ac03f36124a/nejmoa0904492_f1.jpg)
Infliximab Azathioprine Or Combination Therapy For Crohn S Di The comparative efficacy and safety of infliximab and azathioprine therapy alone or in combination for crohn's disease are unknown. in this randomized, double blind trial, we evaluated the efficacy. Identification of inadequate responders to advanced therapy among commercially insured adult patients with crohn’s disease and ulcerative colitis in the united states, bmc gastroenterology, 23.
![юааinfliximabюаб юааazathioprineюаб юааor Combinationюаб юааtherapyюаб юааfor Crohnюабтащюааsюаб юаа юааinfliximabюаб юааazathioprineюаб юааor Combinationюаб юааtherapyюаб юааfor Crohnюабтащюааsюаб юаа](https://videos.files.wordpress.com/rzdBP4bA/sandbornyt_dvd.original.jpg)
юааinfliximabюаб юааazathioprineюаб юааor Combinationюаб юааtherapyюаб юааfor Crohnюабтащюааsюаб юаа Infliximab, azathioprine, or both for crohn’s disease n engl j med 362;15 nejm.org april 15, 2010 1385 (the equivalent of <20 mg or ≥20 mg of prednisone. Background: the comparative efficacy and safety of infliximab and azathioprine therapy alone or in combination for crohn's disease are unknown. methods: in this randomized, double blind trial, we evaluated the efficacy of infliximab monotherapy, azathioprine monotherapy, and the two drugs combined in 508 adults with moderate to severe crohn's. Serious infections developed in 3.9% of patients in the combination therapy group, 4.9% of those in the infliximab group, and 5.6% of those in the azathioprine group. conclusions patients with moderate to severe crohn's disease who were treated with infliximab plus azathioprine or infliximab monotherapy were more likely to have a corticosteroid. Europe pmc is an archive of life sciences journal literature. search life sciences literature (43,496,178 articles, preprints and more) (43,496,178 articles.
![Figure 2 From combination therapy With infliximab And azathioprine Is Figure 2 From combination therapy With infliximab And azathioprine Is](https://ai2-s2-public.s3.amazonaws.com/figures/2017-08-08/5dbe97429ec9e08d70ed2a77e92775161e930473/5-Figure2-1.png)
Figure 2 From Combination Therapy With Infliximab And Azathioprine Is Serious infections developed in 3.9% of patients in the combination therapy group, 4.9% of those in the infliximab group, and 5.6% of those in the azathioprine group. conclusions patients with moderate to severe crohn's disease who were treated with infliximab plus azathioprine or infliximab monotherapy were more likely to have a corticosteroid. Europe pmc is an archive of life sciences journal literature. search life sciences literature (43,496,178 articles, preprints and more) (43,496,178 articles. Infliximab, azathioprine, or combination therapy for crohn's disease. n engl j med. 2010 sep 9;363 (11):1086; author reply 1087 8. doi: 10.1056 nejmc1005805. Infliximab, azathioprine, or combination therapy for crohn's disease publication publication. new england journal of medicine, volume 362 issue 15 p. 1383 1395.
Comments are closed.